STAT

FEBRUARY 1, 2024

So my enterprising colleague John Wilkerson trekked up to Wilmington to give you an inside view on how a key judge viewed arguments in the first court test of the new Medicare drug price negotiation program. Read the rest…

Drug Pricing 191

Drug Pricing 191

STAT

FEBRUARY 8, 2024

Bernie Sanders’ prescription drug pricing theater. WASHINGTON — Call it Sen. The hearing, featuring Merck CEO Robert Davis, Johnson and Johnson CEO Joaquin Duato, and Bristol Myers Squibb CEO Chris Boerner, was designed to draw public interest, and in that respect, it worked.

Drug Pricing 240

Drug Pricing 240

STAT

FEBRUARY 8, 2024

LONDON — Medicare’s first-ever drug pricing negotiations are officially underway. But neither government officials nor drugmakers are wanting to show their cards, at least publicly.

Drug Pricing 258

Drug Pricing Diabetes 258

STAT

MAY 8, 2023

EQRx, a company that aimed to lower drug prices by introducing inexpensive me-too medicines, said Tuesday that it has abandoned that plan and is laying off nearly 60% of its workforce. Continue to STAT+ to read the full story…

Drug Pricing 294

Drug Pricing Hospitals 294

STAT

AUGUST 24, 2023

At the start and halfway points of each year, many pharmaceutical companies raise drug prices to bolster revenue and reportedly fund new research. “It’s not just all selling new drugs,” said Juliette Cubanski, deputy director of the Program on Medicare Policy at Kaiser Family Foundation.

Drug Pricing 224

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 224

STAT

SEPTEMBER 8, 2022

The passage of the Inflation Reduction Act brings a new era to drug pricing in the United States. After decades of being an outlier, it now joins every other developed nation in having the federal government engaged in negotiating drug pricing.

Drug Pricing 238

Drug Pricing 238

STAT

DECEMBER 6, 2023

judge ruled that Minnesota must temporarily halt a controversial law that is designed to provide transparency into prescription drug pricing over concerns that it is unconstitutional. In a victory for the pharmaceutical industry, a U.S.

Drug Pricing 267

Drug Pricing Pharmaceutical Manufacturing 267

STAT

MARCH 9, 2023

WASHINGTON — President Biden made lowering drug prices a key part of his budget with proposals to expand Medicare drug price negotiation, squeeze more rebates out of drug companies, and lower the cost of insulin for everyone with insurance. The request made Thursday also details a $7.2

Drug Pricing 241

Drug Pricing 241

PharmaVoice

AUGUST 18, 2022

Now that Medicare will be able to negotiate drug prices under the Inflation Reduction Act, the industry can expect to see some changes. Here are some tips on how to navigate the changing tide.

Drug Pricing 262

Drug Pricing 262

STAT

AUGUST 15, 2023

As STAT reported recently, the Senate Committee on Health, Education, Labor, and Pensions (HELP) has indicated that it will not consider the nomination of Monica Bertagnolli as director of the National Institutes of Health unless she pledges to take specific steps to reduce drug prices. Read the rest…

Drug Pricing 235

Drug Pricing 235

STAT

JANUARY 23, 2024

Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with a look at some polarizing cancer data, a strange CEO transition, and the importance of New Year cheer. Read the rest…

Drug Pricing 172

Drug Pricing Drug Development 172

STAT

MAY 11, 2023

is pursuing the drug pricing reforms at the behest of Senate Majority Leader Chuck Schumer (D-N.Y.), The markup came just a day after the same panel held a major hearing on PBM and drugmakers’ role in high insulin prices. Chairman Bernie Sanders (I-Vt.)

Drug Pricing 254

Drug Pricing Packaging 254

STAT

OCTOBER 2, 2023

… A federal court judge allowed the new Medicare drug price negotiation program to proceed while the court deliberates whether it is constitutional , STAT reports. Meanwhile, Novo Nordisk became the latest pharmaceutical company to file a lawsuit against the Medicare drug price negotiation program , Bloomberg Law tells us. The

Drug Pricing 244

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 244

STAT

MAY 24, 2023

The goal is to give states more leverage in price negotiations by forcing drugmakers to share and publish details about their pricing data. The government would collect specific drug pricing information from makers of up to 10 particularly high-cost drugs.

Drug Pricing 235

Drug Pricing 235

STAT

JULY 26, 2023

They’re focused this summer on reining in pharmacy middlemen to make the system fairer — but none of their many proposals will actually tackle the core dynamic that has incentivized higher drug prices. There are major packages on so-called PBM reform percolating in at least six different congressional committees.

Drug Pricing 224

Drug Pricing Packaging Pharmaceutical Companies Pharmaceutical Companies 224

STAT

MARCH 8, 2023

WASHINGTON — Medicare officials are still hammering out the technical specifics of how the massive program will start to negotiate drug prices — let alone the substantive ones, Medicare chief Meena Seshamani said at a STAT event Tuesday.

Drug Pricing 203

Drug Pricing 203

PharmaVoice

AUGUST 31, 2023

Medicare just announced its first-ever drug price negotiations and legislators are quickly pushing to broaden the program.

Drug Pricing 147

Drug Pricing 147

Pharmaceutical Commerce

APRIL 8, 2024

In an interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, Value & Access Advisor, Schoonveld Advisory, offers his thoughts on lower drug prices in the US and provides a sneak peak into future PC features.

Drug Pricing 105

Drug Pricing 105

STAT

DECEMBER 1, 2022

At a time when many Americans are clamoring for more transparency into prescription drug pricing, one key provider of that data is making it harder to access the information.

Drug Pricing 236

Drug Pricing Packaging 236

STAT

NOVEMBER 2, 2023

WASHINGTON — A key Senate panel announced it will consider more policies to regulate pharmacy middlemen and ensure patients aren’t paying more than insurers do for medications. The package crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) is slated to be marked up on Nov.

Packaging 331

Packaging Drug Pricing 331

Drug Patent Watch

JANUARY 9, 2024

A recent story by NPR echoes the findings of a collaboration between DrugPatentWatch and Bloomberg, which examined increasing competition between generic drug makers. The NPR article discusses the challenges in… The post NPR on how low Drug Prices can Shortages appeared first on DrugPatentWatch - Make Better Decisions.

Drug Pricing 110

Drug Pricing 110

STAT

MARCH 10, 2023

By law, Medicare will have to take a medication’s efficacy and its research and development costs into account when it starts to negotiate drug prices — but recent research shows pharma companies ignore those factors when they pick prices for their products.

Drug Pricing 239

Drug Pricing 239

STAT

MARCH 20, 2024

WASHINGTON — Medicare will likely choose the obesity drug semaglutide for price negotiation “within the next few years,” according to a new analysis from nonpartisan congressional budget experts.

Drug Pricing 307

Drug Pricing Diabetes 307

STAT

JULY 6, 2023

The trade group for generic drug companies has filed a lawsuit alleging a Minnesota law that is designed to provide transparency into prescription drug pricing is unconstitutional, the latest effort to push back against states attempting to lower the cost of medicines.

Drug Pricing 216

Drug Pricing 216

STAT

DECEMBER 7, 2023

The framework will detail when the agency might assert this authority, and endorse using drug prices when deciding. National Institutes of Health to more broadly use march-in rights, a policy that allows it to seize patents from drugmakers whose products rely on federally funded research. billion , STAT writes.

Drug Pricing 220

Drug Pricing 220

STAT

JULY 24, 2023

You don’t have to be an economist to understand the law of demand: The higher the price, the less likely a customer is to buy a product. It’s not always the customer who decides that the price is too high. This, of course, limits how much companies can charge. Often, it’s the insurer.

Drug Pricing 245

Drug Pricing 245

STAT

JUNE 7, 2023

BOSTON — The drug industry has spent the past year speaking against new mechanisms that could limit how much governments or insurers pay for certain new medicines. Robert Califf, the Food and Drug Administration chief, walked on stage Wednesday and told a crowd of biotech leaders that drug costs needed fixing.

Drug Pricing 355

Drug Pricing Drug Development 355

STAT

SEPTEMBER 20, 2023

T wo months ago, Sen. Bernie Sanders (I-Vt.) moved a step closer to an idea he has championed for some time — awarding prizes, instead of patents, for inventing medicines.

Drug Pricing 327

Drug Pricing 327

STAT

MARCH 27, 2023

When Moderna CEO Stéphane Bancel was called before a Senate committee last week to defend his company’s decision to raise the price of its Covid vaccine, things went largely as one would expect. Progressives tried to pin the Moderna billionaire down as a symbol of corporate greed. Mitt Romney delivered a paean to the free market.

Drug Pricing 240

Drug Pricing Vaccines 240

BioPharma Dive

AUGUST 22, 2023

The pharma’s suit, which claims Medicare’s new power to negotiate certain drug prices is unconstitutional, comes days before the agency will reveal the first 10 medicines to be included under the plan.

Drug Pricing 97

Drug Pricing 97

pharmaphorum

AUGUST 31, 2023

The drug pricing discussion that won’t disappear Mike.Hammerton Thu, 31/08/2023 - 08:00 Bookmark this

Drug Pricing 105

Drug Pricing 105

Drug Channels

MARCH 6, 2023

Experts from across the industry will discuss how current and future drug pricing transparency regulations will impact commercialization, reimbursement, pricing and compliance practices. Drug Channels readers will save 10% off when they use code 23DRCH10 and register prior to March 31, 2023.*

Drug Pricing 83

Drug Pricing 83

STAT

SEPTEMBER 8, 2023

After the recent announcement of the first 10 drugs selected for Medicare price negotiation, much has been discussed about the drugs that were selected and the magnitude of price decreases that can be achieved. Less attention has been given to what this all means for Medicare beneficiaries. 1, 2026.

Drug Pricing 293

Drug Pricing 293

Drug Channels

MAY 21, 2024

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook This event will be broadcast live on Friday, June 21, 2024, from 12:00 p.m. to 1:30 p.m.

Drug Pricing 52

Drug Pricing 52

STAT

JUNE 21, 2023

Pharmacy benefit managers are intermediaries that are supposed to negotiate lower drug costs. Editor’s note: A livestream of the event will be embedded below at 1 p.m. But does the system work for patients? And how can we fix it when it doesn’t? Read the rest…

Drug Pricing 230

Drug Pricing 230

STAT

DECEMBER 16, 2022

The decision comes as regulators begin to implement the drug-pricing provisions of the Inflation Reduction Act that drugmakers spent millions in lobbying to defeat. AbbVie is also leaving the Business Roundtable, a group comprising the chief executives of the largest U.S. Continue to STAT+ to read the full story…

Drug Pricing 219

Drug Pricing 219

Pharmaceutical Commerce

FEBRUARY 14, 2024

Analysis explores where drug prices are derived from, and whether a holistic societal approach can help determine these products’ true value.

Drug Pricing 52

Drug Pricing 52